A Clinical Trial to Evaluate the Effects of Adrenal Adapt on Sleep Quality, Daytime Energy, Stress Resilience, and Cognitive Performance.

Inclusion criteria

• Adults aged 18-60 years at the time of enrollment.
• Experiencing difficulty with at least two of the following: sleep quality (including difficulty falling asleep, nighttime awakenings, or unrefreshing sleep), daytime fatigue or low energy, and/or subjective feelings of elevated stress.
• Generally healthy - does not live with any uncontrolled chronic disease that would interfere with study participation or confound study outcomes.
• If currently taking medications, supplements, or herbal remedies targeting sleep, stress, or energy, willing to maintain that routine unchanged for the study duration without introducing any other new products.
• Willing to take 1 capsule of Adrenal Adapt three times daily with a meal (morning, afternoon, evening) for 12 weeks, not exceeding 3 capsules per day.
• Willing to avoid excessive caffeine and alcohol for the duration of the study, defined as more than 400mg of caffeine per day, more than 15 alcoholic drinks per week for men and more than 7 alcoholic drinks per week for women.
• Willing to maintain their current diet, sleep habits, and activity levels for the duration of the trial.
• Resides in the United States with a valid shipping address.
• Has consistent access to a smartphone or computer and a reliable internet connection sufficient to complete digital surveys.

Exclusion criteria

• Currently pregnant, breastfeeding, or planning to become pregnant at any point during the study period.
• Currently taking anticoagulant medications (e.g., warfarin, heparin, or direct oral anticoagulants), as specified in the product's known contraindications.
• Known allergy or hypersensitivity to any ingredient in Adrenal Adapt (including Hypromellose capsule shell, white rice flour, stearic acid, silicon dioxide, or any of the botanical extracts).
• Diagnosed with a clinically significant psychiatric disorder (e.g., major depressive disorder or bipolar disorder) that could confound subjective outcome assessments or interfere with study participation.
• Diagnosed with a sleep disorder for which pharmacological treatment has been prescribed (e.g., narcolepsy, sleep apnea treated with a CPAP device and prescription medications, insomnia disorder treated with prescription hypnotics).
• Generated by Citruslabs · 02c23d89-a524-4659-bc54-5792f4592244 Planning to introduce any new prescription medications, supplements, or herbal products targeting sleep, stress, or energy during the study period.
• History of substance use disorder or currently using recreational drugs that may affect sleep or stress physiology.
• Planning surgery or a major medical procedure during the 12- week study period.
• Currently enrolled in or planning to enroll in another research study during the study period.